Nucleus Presents “Real Estate for Psychedelics – the Healing REIT” During Psychedelic Series
Updated: Apr 18
Nucleus, a venture studio for psychedelics wholly owned by Iter Investments, will present its monthly Psychedelic Series at Soho Beach House Miami on Thursday, February 9 at 7 p.m. Moderated by psychedelics expert Dustin Robinson, Esq. CPA, panelists include Stanley Cup champion and Wesana CEO Daniel Carcillo and Managing Partner at Ambria Capital and Phyto Partners Cody Shandraw. The topic of the panel is, “Real Estate for Psychedelics – the Healing REIT.”
Carcillo and Shandraw are founders of Healing REIT, alongside CEO Ty Zakovich. Healing REIT invests in real estate designed for innovative medicine. The current healthcare infrastructure does not support the already, and soon-to-be approved, FDA-novel therapies like ketamine, MDMA and psilocybin-assisted therapy. As a real estate investment trust that connects investors to clinics looking to adopt psychedelic therapies and other novel treatment options, Healing REIT is creating a win-win situation for those looking to invest in this budding industry and clinicians looking to provide the best treatment possible to their patients.
Launched in June 2021 by Robinson and visionary leader Sam Baum, the Psychedelic Series has seen great success, hosting over 25 panels with over 75 notable speakers and over 1,500 people in attendance. The Psychedelic Series features experts in the psychedelics space including CEOs, doctors, lawyers and celebrities. The panel started at Soho Beach House Miami and expanded to locations throughout the country including New York, Chicago and California, as well as internationally in London and Amsterdam. Past panelists include MAPS Founder Rick Doblin, NBA champion Lamar Odom, Psilera Bioscience CEO Chris Witowski, PhD, Silo Wellness CEO Douglas K. Gordon, and others.
Robinson is Founding Partner of Mr. Cannabis Law – a full service law firm focused on the cannabis and psychedelic industries; Co-Founder of Mr. Psychedelic Law – a non-profit focused on psychedelic legal reform; Managing Principal of Iter Investments – a venture capital firm deploying capital across the psychedelic ecosystem; and Co-Founder of Nucleus – a platform with various tools to help guide individuals on their mental health journey.
Carcillo founded Wesana Health after his own personal experience with psychedelics in healing brain injuries he obtained as a hockey player. He’s a two-time Stanley Cup winner with the Chicago Blackhawks, however Carcillo was forced into early retirement when he was just 30 after suffering from post-concussion syndrome. His recovery, due in large part to psychedelics, led him to found Wesana Health. Wesana Health is an emerging life sciences company championing the development and delivery of therapies, including psychedelics, to treat traumatic brain injury (TBI) and related conditions. Through extensive clinical research and academic partnerships, the company is developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological and mental health ailments caused by trauma.
Shandraw has been a serial entrepreneur from an early age, striving to be a proven producer of profit in all of his ventures. Shandraw serves as a Managing Partner at Ambria Capital and Phyto Partners. He manages market assessment projects and due diligence, as well as client relationships. He oversees one of the most active due diligence programs in the psychedelics industry, focused on early-stage companies and non-traditional venture opportunities. Shandraw is passionate about advocating for psychedelic-assisted therapies and advancing their place in the mental healthcare landscape. To date, he and his team have backed more than 50 companies and supported many in growth to scale. He was recently recognized and honored as the 2021 Investor of the Year at the first annual Microdose Awards.
The event is private and open to Soho House members.